Vera Therapeutics (VERA) Income Statement: Revenue & Earnings

Vera Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Vera Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	1.93	1.93	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	1.93	1.93	0.00	0.00
Operating Expenses
Research & Development	126.17	78.23	68.99	22.48	45.21
Selling, General & Administrative	41.00	23.79	21.91	11.92	4.04
Operating Expenses	167.17	102.01	90.90	34.40	49.25
Operating Income	-167.17	-102.01	-90.90	-34.40	-49.25
Other Income/Expense
Interest Income	20.71	7.98	1.75	0.02	0.01
Interest Expense	7.63	-3.79	-0.99	0.02	-0.17
Other Income/Expense	15.02	1.83	1.09	1.80	0.06
Income
Income Before Tax	-152.15	-95.99	-89.06	-32.61	-53.41
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-152.15	-95.99	-89.06	-32.61	-53.41
Net Income - Continuous Operations	-152.15	-95.99	-89.06	-32.61	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-144.42	-101.99	-88.06	-32.41	-48.99
EBIT	-152.15	-102.01	-88.06	-32.59	-49.25
Depreciation & Amortization	0.11	0.02	0.18	0.18	0.25
Earnings Per Share
Basic EPS	-3.00	-2.00	-3.00	-2.00	-167.00
Diluted EPS	-3.00	-2.00	-3.00	-2.00	-167.00
Basic Shares Outstanding	55.33	42.71	26.57	13.44	0.32
Diluted Shares Outstanding	55.33	42.71	26.57	13.44	0.32